|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Panera N, Gnani D, Crudele A, Ceccarelli
S, Nobili V and Alisi A: MicroRNAs as controlled systems and
controllers in non-alcoholic fatty liver disease. World J
Gastroenterol. 20:15079–15086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: microRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siomi H and Siomi MC: On the road to
reading the RNA-interference code. Nature. 457:396–404. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Z, Wang XL, Bai R, Liu WY, Li X, Liu
M and Tang H: miR-23a promotes IKKα expression but suppresses ST7L
expression to contribute to the malignancy of epithelial ovarian
cancer cells. Br J Cancer. 115:731–740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aghaee-Bakhtiari SH, Arefian E, Naderi M,
Noorbakhsh F, Nodouzi V, Asgari M, Fard-Esfahani P, Mahdian R and
Soleimani M: MAPK and JAK/STAT pathways targeted by miR-23a and
miR-23b in prostate cancer: Computational and in vitro approaches.
Tumour Biol. 36:4203–4212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wen YC, Lee WJ, Tan P, Yang SF, Hsiao M,
Lee LM and Chien MH: By inhibiting snail signaling and miR-23a-3p,
osthole suppresses the EMT-mediated metastatic ability in prostate
cancer. Oncotarget. 6:21120–21136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Donadelli M, Dando I, Fiorini C and
Palmieri M: Regulation of miR-23b expression and its dual role on
ROS production and tumour development. Cancer Lett. 349:107–113.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bookman MA: Optimal primary therapy of
ovarian cancer. Ann Oncol. 27 Suppl 1:i58–i62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suh DH, Kim HS, Chang SJ and Bristow RE:
Surgical management of recurrent ovarian cancer. Gynecol Oncol.
142:357–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blower PE, Chung JH, Verducci JS, Lin S,
Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, et
al: MicroRNAs modulate the chemosensitivity of tumor cells. Mol
Cancer Ther. 7:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du T and Zamore PD: microPrimer: The
biogenesis and function of microRNA. Development. 132:4645–4652.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S and Olson EN: AngiomiRs-key
regulators of angiogenesis. Curr Opin Genet Dev. 19:205–211. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gounaris-Shannon S and Chevassut T: The
role of miRNA in haematological malignancy. Bone Marrow Res.
2013:2691072013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S,
Lobie PE and Zhu T: c-MYC-regulated miR-23a/24-2/27a cluster
promotes mammary carcinoma cell invasion and hepatic metastasis by
targeting sprouty2. J Biol Chem. 288:18121–18133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang S, He X, Ding J, Liang L, Zhao Y,
Zhang Z, Yao X, Pan Z, Zhang P, Li J, et al: Upregulation of
miR-23a approximately 27a approximately 24 decreases transforming
growth factor-beta-induced tumor-suppressive activities in human
hepatocellular carcinoma cells. Int J Cancer. 123:972–978. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin AH, Zhou XP and Zhou FZ: Inhibition of
microRNA-23a increases cisplatin sensitivity of ovarian cancer
cells: The possible molecular mechanisms. Nan Fang Yi Ke Da Xue Xue
Bao. 35:125–128. 2015.(In Chinese). PubMed/NCBI
|
|
20
|
Zhuang K, Han K, Tang H, Yin X, Zhang J,
Zhang X and Zhang L: Up-regulation of plasma miR-23b is associated
with poor prognosis of gastric cancer. Med Sci Monit. 22:356–361.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan J, Jiang JY, Meng XN, Xiu YL and Zong
ZH: MiR-23b targets cyclin G1 and suppresses ovarian cancer
tumorigenesis and progression. J Exp Clin Cancer Res. 35:312016.
View Article : Google Scholar : PubMed/NCBI
|
